Alexander Y. Tokman, Director at ENDRA Life Sciences Inc. (NDRA), sold 10,000 shares at $0.90 ($9K) on 2021-01-08, disclosed to the SEC on 2021-01-08.
Scheduled sale ($9k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NDRA | BUY | 2022-05-17 | $20K | — | Filing → |
| MVIS | BUY | 2016-12-14 | $100K | — | Filing → |
| MVIS | BUY | 2015-11-16 | $23K | — | Filing → |